Verified by Psychology Today

Lantie Elisabeth Jorandby M.D.

About

Lantie Jorandby, M.D., is a board-certified psychiatrist with a specialty certification in Addiction Psychiatry and Addiction Medicine. She completed her general psychiatry training at the University of Florida and her Addiction Psychiatry training at Yale School of Medicine. She has served as medical director of the dual diagnosis unit at McLean Hospital and as faculty with Harvard Medical School.

She is currently Chief Medical Officer of Lakeview Health, a residential facility in Jacksonville, Florida, that specializes in treating addictive and psychiatric disorders.

Recent Posts
Eating Disorders and the Brain

It is increasingly clear that neurobiology is a key to understanding eating disorders. That may have a profound effect on how these mental illnesses are treated.

It is increasingly clear that neurobiology is a key to understanding eating disorders. That may have a profound effect on how these mental illnesses are treated.

Women Need Addiction Treatment, Too

Women are often held back from seeking care because of stigma and other barriers. These strategies can help change that.

Women are often held back from seeking care because of stigma and other barriers. These strategies can help change that.

A 360-Degree Approach to Addiction

We often seem to fight addiction with one (or both!) arms behind our backs. Here's a more comprehensive treatment approach that works.

We often seem to fight addiction with one (or both!) arms behind our backs. Here's a more comprehensive treatment approach that works.

A Ban on Certain Tobacco Products May Be Here Soon

The FDA is taking action to ban flavored cigars and menthol cigarettes from retail store shelves. It's about time.

The FDA is taking action to ban flavored cigars and menthol cigarettes from retail store shelves. It's about time.

Update on Medications for Opioid Use Disorder

Some say medications for opioid use disorder (MOUD) are merely substituting one drug for another. That thinking needs to change, because lives are at stake.

Some say medications for opioid use disorder (MOUD) are merely substituting one drug for another. That thinking needs to change, because lives are at stake.